Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LY139603 Bioequivalence Study Comparing Atomoxetine Oral Solution and Capsule Formulation in Healthy Adult Male Japanese Subjects.

Next Previous
Trial Profile

LY139603 Bioequivalence Study Comparing Atomoxetine Oral Solution and Capsule Formulation in Healthy Adult Male Japanese Subjects.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 08 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Anxiety disorders; Attention-deficit hyperactivity disorder; Fetal alcohol syndrome; Huntington's disease; Social phobia
  • Focus Pharmacokinetics
  • Sponsors Eli Lilly and Company

Most Recent Events

  • 01 Nov 2016 Primary endpoint (Area Under the Curve From Time Zero to Last Quantifiable Concentration [AUC (0-tlast)]) has been met, according to results published in the Clinical Drug Investigation.
  • 01 Nov 2016 Primary endpoint (Maximum Observed Plasma Concentration (Cmax)) has been met, according to results published in the Clinical Drug Investigation.
  • 01 Nov 2016 Results published in the Clinical Drug Investigation

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top